"Clinical research trials for depression, bipolar disorder, and schizophrenia. We focus on helping patients with these disorders contribute to the research, while we provide state of the art care. We are a well-respected and well-recognized clinical trials center in Maryland. We work with participants from the surrounding areas of Gaithersburg, Baltimore, and Washington DC, as well as nationwide for those who can commute."

During the past decade, CBH Health LLC conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 20 clinical trials were completed, i.e. on average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 17 clinical trials were completed. i.e. 89.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CBH Health LLC" #1 sponsor was "Sunovion" with 7 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 6 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CBH Health LLC" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Centers for Behavioral Health, LLC" with 1 trials as a collaborator, "Clinical Innovations" with 1 trials as a collaborator and "Cognitive Research Corporation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "CBH Health LLC" are "Schizophrenia" (23 trials), "Depressive Disorder, Major" (8 trials), "Bipolar I Disorder" (3 trials), "Depressive Disorder, Treatment-Resistant" (2 trials) and "Schizophrenia, Schizoaffective Disorder" (2 trials). Many other conditions were trialed in "CBH Health LLC" in a lesser frequency.

Most popular intervention types in "CBH Health LLC" are "Drug" (46 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Rapastinel" (6 trials), "Brexpiprazole" (2 trials), "Esketamine" (2 trials) and "Esketamine 56 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "CBH Health LLC" are 46 trials for "All" genders.

Currently, there are NaN active trials in "CBH Health LLC". undefined are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in CBH Health LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CBH Health LLC, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".